Journal of the American Society of Hypertension
Volume 1, Issue 1 , Pages 17-29, January 2007

Nitric oxide signaling in vascular biology

  • Ka Bian, MD, PhD

      Affiliations

    • The Institute of Molecular Medicine, The University of Texas-Houston Medical School, Houston, Texas, USA
    • The Murad Research Institute for Modernized Chinese Medicine and Shanghai University of Traditional Chinese Medicine, Shanghai, China
    • E-Research Institute of Nitric Oxide and Inflammatory Medicine of Shanghai Universities, Shanghai, China
  • ,
  • Ferid Murad, MD, PhD

      Affiliations

    • The Institute of Molecular Medicine, The University of Texas-Houston Medical School, Houston, Texas, USA
    • The Murad Research Institute for Modernized Chinese Medicine and Shanghai University of Traditional Chinese Medicine, Shanghai, China
    • Corresponding Author InformationCorresponding authors: Ka Bian, MD, PhD, and Ferid Murad, MD, PhD, The Institute of Molecular Medicine, The University of Texas-Houston Medical School, 6431 Fannin, Houston, Texas 77030. Tel: 713-500-2469; fax: 713-500-2447.

Received 17 November 2006; accepted 17 November 2006.

Abstract 

Nitric oxide (NO) research has expanded rapidly in the past 20 years, and the role of NO in physiology and pathology has been extensively studied. This review focuses on the pathways of NO synthesis and metabolism in vascular biological systems. Healthy vascular homeostasis is dependent on the integrity of the endothelium, which is a very large dynamic autocrine and paracrine organ with vasodilator, anti-inflammatory, and antithrombotic properties. The importance and relevance of NO signaling is stressed in this review. The potential role of nitrotyrosine formation with vascular pathological conditions is discussed. The use of pharmacologic, biochemical, and molecular biological approaches to characterize, purify, and reconstitute these regulatory pathways should lead to the development of new therapies for various pathological conditions that are characterized by an insufficient production of NO. With more than 77,000 publications in the field of NO signaling, this brief review can only focus on some aspects of the field as it applies to vascular biology. Many molecular targets have been identified for drug development dealing with NO and cyclic guanosine monophosphate formation, metabolism, and function. Many agents have been identified that are in pre-clinical evaluation or in clinical trials. Certainly, many should prove to be important therapeutic additions during the next decade.

Keywords: Nitric oxide, vascular function, nitrovasodilator, protein nitration

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of interest: none.The financial support for this research was provided by the John S. Dunn, Harold and Leila Mathers, and Robert A. Welch Foundations (AU-1437); National Institute of General Medical Sciences Grant (GM-061731); The Department of Defense (T5 project); as well as The University of Texas and The Shanghai University of TCM. We also acknowledge the support of National Natural Science Foundation (30570710); E-Institutes for Nitric Oxide and Inflammatory Medicine (E-04010) and Key Project (05ZZ11) from Shanghai Municipal Education Commission; Key Project of Shanghai Committee of Science & Technology (05JC14056).

PII: S1933-1711(06)00008-8

doi:10.1016/j.jash.2006.11.007

Journal of the American Society of Hypertension
Volume 1, Issue 1 , Pages 17-29, January 2007